Документ взят из кэша поисковой машины. Адрес оригинального документа : http://www.enzyme.chem.msu.ru/~tishkov/Publications/BiotechBioeng99.html
Дата изменения: Fri Jan 21 14:51:22 2000
Дата индексирования: Mon Oct 1 23:10:49 2012
Кодировка:
PubMed medline query Entrez medline Query

Other Formats:[Citation Format][MEDLINE Format]
Links:[98 medline neighbors]

Order this document

Biotechnol Bioeng 1999 Jul 20;64(2):187-93

Pilot scale production and isolation of recombinant NAD+- and NADP+-specific formate dehydrogenases.

Tishkov VI, Galkin AG, Fedorchuk VV, Savitsky PA, Rojkova AM, Gieren H, Kula MR

Department of Chemical Enzymology, Faculty of Chemistry, M. V. Lomonosov Moscow State University, 119899 Moscow, Russian Federation. vit@enz.chem.msu.ru

The expression of the recombinant wild-type NAD+- and mutant NADP+-dependent formate dehydrogenases (EC 1.2.1.2., FDH) from the methanol-utilizing bacterium Pseudomonas sp. 101 in Escherichia coli cells has been improved to produce active and soluble enzyme up to the level of 50% of total soluble proteins. The cultivation process for E. coli/pFDH8a and E. coli/pFDH8aNP cells was optimized and scaled up to a volume of 100 L. A downstream purification process has been developed to produce technical grade NAD+- and NADP+-specific formate dehydrogenases in pilot scale, utilizing extraction in aqueous two-phase systems. Copyright 1999 John Wiley & Sons, Inc.

PMID: 10397854, UI: 99326252


Full text paper in PDF format 

the above report in format
documents on this page through Loansome Doc